1. Home
  2. MCRB vs ACR Comparison

MCRB vs ACR Comparison

Compare MCRB & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • ACR
  • Stock Information
  • Founded
  • MCRB 2010
  • ACR 2005
  • Country
  • MCRB United States
  • ACR United States
  • Employees
  • MCRB N/A
  • ACR N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • ACR Real Estate Investment Trusts
  • Sector
  • MCRB Health Care
  • ACR Real Estate
  • Exchange
  • MCRB Nasdaq
  • ACR Nasdaq
  • Market Cap
  • MCRB 144.8M
  • ACR 143.3M
  • IPO Year
  • MCRB 2015
  • ACR N/A
  • Fundamental
  • Price
  • MCRB $16.87
  • ACR $21.43
  • Analyst Decision
  • MCRB Hold
  • ACR Buy
  • Analyst Count
  • MCRB 3
  • ACR 2
  • Target Price
  • MCRB $14.33
  • ACR $24.50
  • AVG Volume (30 Days)
  • MCRB 88.5K
  • ACR 21.2K
  • Earning Date
  • MCRB 11-05-2025
  • ACR 10-29-2025
  • Dividend Yield
  • MCRB N/A
  • ACR N/A
  • EPS Growth
  • MCRB N/A
  • ACR 14.65
  • EPS
  • MCRB 0.62
  • ACR 0.95
  • Revenue
  • MCRB $351,000.00
  • ACR $88,952,000.00
  • Revenue This Year
  • MCRB N/A
  • ACR $7.03
  • Revenue Next Year
  • MCRB N/A
  • ACR $3.26
  • P/E Ratio
  • MCRB $26.91
  • ACR $22.50
  • Revenue Growth
  • MCRB N/A
  • ACR 14.87
  • 52 Week Low
  • MCRB $6.53
  • ACR $14.94
  • 52 Week High
  • MCRB $24.67
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 51.80
  • ACR 59.20
  • Support Level
  • MCRB $12.48
  • ACR $21.29
  • Resistance Level
  • MCRB $14.35
  • ACR $19.62
  • Average True Range (ATR)
  • MCRB 1.18
  • ACR 0.46
  • MACD
  • MCRB 0.22
  • ACR 0.10
  • Stochastic Oscillator
  • MCRB 80.50
  • ACR 81.40

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: